Outlook Therapeutics Inc. (OTLK) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Outlook Therapeutics Inc.

    NASDAQ: OTLK · Real-Time Price · USD
    0.97
    -0.00 (-0.40%)
    At close: Sep 26, 2025, 3:59 PM
    0.98
    1.02%
    Pre-market: Sep 29, 2025, 06:53 AM EDT

    Outlook Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Cash & Equivalents
    		 14.93M 23.39M 17.4M 14.48M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 693.19K 793.93K 804.93K 853.66K
    Other Long-Term Assets
    		 439.28K 501.3K 132.01K 174.59K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 12.49M 7.59M n/a 324.00
    Total Current Assets
    		 27.42M 30.98M 27.52M 21.51M
    Property-Plant & Equipment
    		 274.64K 26.17K 70.36K 275.05K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.41M 1.32M 1.01M 1.3M
    Total Assets
    		 28.82M 32.3M 28.53M 22.81M
    Account Payables
    		 7.97M 6.57M 3.49M 2.2M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 29.44M 35.55M 10.92M 904.2K
    Other Current Liabilities
    		 n/a 1.83M 1.45M 2.83M
    Total Current Liabilities
    		 42.55M 46.73M 19.73M 6.75M
    Long-Term Debt
    		 n/a n/a n/a 10.89M
    Other Long-Term Liabilities
    		 59.1M 6.22K 57.14K 522.92K
    Total Long-Term Liabilities
    		 59.35M 6.22K 61.41K 11.45M
    Total Liabilities
    		 101.9M 46.74M 19.79M 18.2M
    Total Debt
    		 29.74M 35.56M 10.96M 11.9M
    Book Value
    		 -73.08M -14.44M 8.74M 4.61M
    Book Value Per Share
    		 -3.94 -1.15 0.82 0.60
    Common Stock
    		 239.06K 2.6M 2.27M 1.76M
    Retained Earnings
    		 -543.28M -467.92M -408.94M -342.88M
    Comprehensive Income
    		 n/a -32,300.6B 417.67M -22,811.5B
    Shareholders Equity
    		 -73.08M -14.44M 8.74M 4.61M
    Total Investments
    		 693.19K 793.93K 804.93K 853.66K

    Add to Watchlist